Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitevoyagertherapeuti...
CategoryBioTech
Emailinfo@voyagerthera...
Employees

Offices

Cambridge, USA
75 Sidney St.
Cambridge, MA, 02139
USA

People

Funding

TOTAL $45M
FUNDING TOTAL $45M
Series A, 2/2014
Third Rock Ventures
$45M

Tags

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). Voyager is committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production.

The company’s initial pipeline is focused on CNS diseases in dire need of effective new therapies, including Parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (ALS), and Friedreich’s ataxia.

Founded by scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference and neuroscience, Voyager Therapeutics was launched in 2014 with funding from leading life sciences investor Third Rock Ventures and is headquartered in Cambridge, Mass.

Recent Milestones

Videos

Screenshots

Voyager Therapeutics screenshot
Above: Homepage
Uploaded: 2/12/14

Sources

  1. Voyager Therapeutics Launches with $45M in Series A Financing (finsmes.com) [edit]
Edit This Page
Last Edited 2/13/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy